All Infection articles
-
NICE guidelineCOVID-19 rapid guideline: managing COVID-19 symptoms in the community
The purpose of this guideline is to provide recommendations for managing COVID‑19 symptoms for patients in the community, including at the end of life. It also includes recommendations about managing medicines for these patients, and protecting staff from infection
-
NICE guideline
COVID-19 rapid guideline: cystic fibrosis
The purpose of this Guidelines summary is to maximise the safety of patients with cystic fibrosis and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match capacity to patient needs if services become limited because of the COVID-19 pandemic.
-
PHE/DH/DWP guideline
PHE rabies post-exposure treatment guideline
A concise easy-to-read summary on the risk assessment and post-exposure management of patients who may be at risk of rabies infection.
-
News
SIGN publishes management of suspected bacterial lower UTI in adult women
The new guideline provides recommendations for the diagnosis and management of suspected bacterial lower urinary tract infection in adult women, and replaces SIGN 88 on management of suspected bacterial urinary tract infection in adults
-
News
New NICE guideline on insect bites and stings: antimicrobial prescribing
NICE has published NICE Guideline 182, an antimicrobial prescribing strategy for insect and spider bites and stings
-
Independent professional body guideline
PSNC Seasonal flu service specification
NHS England and NHS Improvement has commissioned an advanced service for community pharmacies to provide flu vaccinations in order to improve access to NHS flu vaccination for eligible patients
-
NICE guideline
COVID-19 rapid guideline: dialysis service delivery
This Guidelines summary covers the provision of care for patients requiring dialysis in the context of the COVID-19 outbreak
-
PHE/DH/DWP guideline
PHE COVID-19 infection prevention and control guidance
Summary of the latest UK guidance on infection prevention and control measures for COVID-19.
-
NHS guideline
NHS England COVID-19 community pharmacy guideline
This standard operating proedure summary sets out general principles for the delivery of services during the COVID-19 pandemic, and requires local interpretation
-
NHS guideline
NHS video consulting guideline
This Guidelines summary covers guidance for safe video consulting in general practice. It includes key principles, general information, and recommendations on conducting safe video consultations. Refer to the full guideline for information on: information governance communication with colleagues medico-legal information ...
-
NICE guideline
COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response
The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic.
-
PHE/DH/DWP guideline
PHE guideline on management of exposure to COVID-19
This summary provides guidance on the management of staff and patients in health and social care settings according to exposures, symptoms, and test results.
-
NHS guideline
General practice in the context of coronavirus (COVID-19)
This Guidelines summary outlines standard operating procedures for general practices in the context of COVID-19.
-
PHE/DH/DWP guideline
PHE whooping cough vaccination in pregnancy guideline
A concise summary covering the pertussis vaccination programme for pregnant women.
-
NHS guideline
NHS guidance on NSAIDs in COVID-19
This summary sets out the clinical policy for the acute use of non-steroidal anti-inflammatory drugs (NSAIDs) in people with or at risk of COVID-19.
-
PHE/DH/DWP guideline
PHE pneumococcal vaccination guideline (Green Book chapter 25)
A succinct summary of Public Health England’s Green Book chapter 25 pneumococcal vaccination programme
-
Independent professional body guideline
Recognition and management of sepsis in general practice
This Guidelines summary combines recommendations from The UK Sepsis Trust to give guidance on the recognition and management of sepsis in adults, children, and young people over 12 years of age
-
NICE guideline
COVID-19 rapid guideline: delivery of systemic anticancer treatments
This guideline aims to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match the capacity for cancer treatment to patient needs if services become limited because of the COVID-19 pandemic
-
NICE guideline
COVID-19 rapid guideline: children and young people who are immunocompromised
The purpose of this guideline is to maximise the safety of children and young people who are immunocompromised during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.
-
NICE guideline
COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders
The purpose of this guideline is to maximise the safety of children and adults with rheumatological autoimmune, inflammatory and metabolic bone disorders during the COVID-19 pandemic, while protecting staff from infection. It also enables services to make the best use of NHS resources
